Fusion Antibodies PLC Ordinary Shares (FAB)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

6.20p

Buy

6.50p

arrow-down-0.25p (-3.79%)

Prices updated at 05 Jun 2025, 16:29 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Fusion Antibodies PLC is engaged in the research, development and manufacturing of recombinant proteins and antibodies, particularly in the areas of cancer and infectious diseases.
FTSE All-Share
arrow-up0.08%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. Simon Gordon Douglas
CEO
Dr. Adrian Robert Kinkaid
Most recent earnings
31 Mar 2024
Fiscal year end
31 Mar 2024
Employees
24
Head office
1 Springbank Road
Belfast
United Kingdom
BT17 0QL
mobile
+44 2890432800
letter
info@fusionantibodies.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. Simon Gordon Douglas
Non-Executive Director, Chairman
-
Mr. Colin James Walsh
Non-Executive Director
-
Mr. Matthew Paul Baker
Non-Executive Director
-
Dr. Richard John Buick
Executive Director, Chief Scientific Officer
-
Dr. Adrian Robert Kinkaid
Executive Director, Chief Executive Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Unicorn Asset Management Ltd6,397,290
Unicorn AIM VCT Series 3 ORD6,397,290
Octopus Investments Limited1,457,635
Baronsmead Second Venture Trust935,484
Octopus AIM VCT ORD870,968

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
12 May 2025Purchase
12 May 2025Purchase
12 May 2025Purchase
06 May 2025Purchase
22 Oct 2024Purchase
22 Oct 2024Purchase
22 Oct 2024Purchase
16 Oct 2024Purchase
09 Sep 2024Purchase
04 Sep 2024Purchase
22 Jul 2024Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.